ハイパルトロフィック心筋病における超収縮性フェノタイプは,不利な血液動力学,冠動脈の流れおよび予後を示唆する
Karina Wierzbowska-Drabik1, Eszter Dalma Pálinkás2, Maria Grazia D'Alfonso3
1Department of Internal Diseases and Clinical Pharmacology, Medical University of Lodz, ul. Kniaziewicza 1/5, 91-347 Lodz, Poland.
European heart journal. Cardiovascular Imaging
|August 29, 2025
まとめ
ハイパルトロフィック心筋病 (HCM) の左心房の超収縮性現象型 (HP) は,心臓機能の低下と,エジェクション分子が保存された患者の長期生存率の低下と関連しています.
科学分野:
- 心臓病科
- 心血管の生理学
- エコカルディオグラフィー
背景:
- ハイパルトロフィック心筋病 (HCM) は複雑な遺伝性心疾患である.
- HCMにおける左心房 (LV) の超収縮性フェノタイプ (HP) の臨床的および予後的意義は不明である.
- 保存されたエジェクション分数 (EF) はHCM患者で一般的ですが,結果は異なる場合があります.
研究 の 目的:
- ハイパルトロフィック心筋病 (HCM) の LV 超収縮性フェノタイプ (HP) の臨床的および予後的意義を評価する.
- 血液動力学プロファイルとHPに関連する長期生存率を,保存されたEFのHCM患者で調べる.
主な方法:
- EF ≥50%の1533人のHCM患者は,トランストラシックエコーカルディオグラフィー (TTE) を受けました.
- LVフォースを計算し (シストリック血圧+LVOTG/ESV),HPを最高四分位数 (> 7. 32 mmHg/mL) として定義した.
- 生存分析は,フォローアップデータを持つ1200人の患者に実施された.
主要な成果:
- HP患者は心拍数が高く,脳卒中量が低く,左心房の体積指数が高く,冠動脈の流れが増加しました.
- LVの力は,LVEFと適度に相関し,LVの流出経路のグラデーション (LVOTG) と弱い.
- 7. 32 mmHg/ mL以上の力は,独立してすべての原因による死亡の1. 44倍の増加と関連していました (HR1. 44,95%CI 1. 00- 2.07).
結論:
- HCMにおけるLV超収縮性フェノタイプ (HP) は,不良な全身,心臓,冠動脈の血液動力学プロファイルと関連しています.
- 保存されたEF患者におけるHPは,長期生存率が著しく低下している.
- これらの発見は,HCMの管理におけるLV力の予測的重要性を強調しています.
関連する概念動画
Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Heart Failure II: Pathophysiology
37
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
37
Cardiomyopathy V: Interprofessional Care
32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
Imbalances in Cardiac Output
1.5K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21


